Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FUCZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,577
Award facts
- Contract value 100% obligated
- $7,577.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,577.19 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on September 25, 2025. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a monoclonal antibody used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions, making this delivery order part of the agency's pharmaceutical procurement for military healthcare support.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The parent contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated its capability to meet federal procurement requirements through competitive award processes and maintains a significant portfolio of federal medical supply contracts across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FUCZX?
SPE2DB25FUCZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FUCZX worth?
The government has obligated $7,577 on SPE2DB25FUCZX.
Is contract SPE2DB25FUCZX an order under another contract?
Yes. SPE2DB25FUCZX is a delivery order under SPE2DB25D3306, an indefinite delivery contract.
Was contract SPE2DB25FUCZX competed?
The extent of competition for SPE2DB25FUCZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award